Home › Hidradenitis Suppurativa › New York
Pag-aaral pangklinika para sa Hidradenitis Suppurativa sa New York
7 pag-aaral para sa Hidradenitis Suppurativa ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Cameron Dermatology, New York
- Icahn School Of Med At Mount Sinai, New York
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07665437A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Equity Medical (LLC)- Site Number : 8400010, The Bronx
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07225569Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 5, New York
- Clinical Site 4, The Bronx
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07828860Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Dr Bobby Buka, Md Greenwich Village, New York
- Equity Medical, Llc, New York
Nagre-recruitPhase 1
Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07049575Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US082, East Syracuse
- Investigative Site US034, New York
- Investigative Site US081, New York
- at 3 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06855498A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Equity Medical, LLC, The Bronx
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07384975A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Northwell Health Physician Partners, Lake Success
- Mount Sinai Doctors, New York
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT07244263Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.